Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study
Title:
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study
Author:
Touchefeu, Y. Bailly, C. Frampas, E. Eugène, T. Rousseau, C. Bourgeois, M. Bossard, C. Faivre-Chauvet, A. Rauscher, A. Masson, D. David, A. Cerato, E. Carlier, T. Sharkey, R. M. Goldenberg, D. M. Barbet, J. Kraeber-Bodere, F. Bodet-Milin, C.
Appeared in:
European journal of nuclear medicine and molecular imaging